Euromedis Groupe SA (ALEMG) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

EUR 11 Million ()

P/E

0.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.45

Return on Equity

440.69%

Price to Book

0.69

Revenue and Profits:

Net Sales:

20 Million

(Quarterly Results - Jan 2013)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.09%

6 Months

1.03%

1 Year

-11.69%

2 Years

-25.85%

3 Years

-16.29%

4 Years

-56.09%

5 Years

-68.05%

Euromedis Groupe SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

16.67%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

13.98

Net Debt to Equity (avg)

-0.43

Sales to Capital Employed (avg)

2.85

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

418.55%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.67

EV to EBIT

EV to EBITDA

EV to Capital Employed

0.42

EV to Sales

0.04

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

444.05%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jan'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jan 2013 is -46.72% vs 11.25% in Jan 2012",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jan 2013 is -100.00% vs 11.25% in Jan 2012",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jan'13",
        "Jan'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.50",
          "val2": "36.60",
          "chgp": "-46.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "36.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -33.21% vs -51.56% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.39% vs -356.52% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.20",
          "val2": "54.20",
          "chgp": "-33.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "-4.70",
          "chgp": "114.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.10",
          "val2": "-5.90",
          "chgp": "-3.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.70%",
          "val2": "-106.80%",
          "chgp": "11.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jan'13 - YoY

Jan'13

Jan'12

Change(%)

Net Sales

19.50

36.60

-46.72%

Operating Profit (PBDIT) excl Other Income

0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.00

36.60

-100.00%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jan 2013 is -46.72% vs 11.25% in Jan 2012

Consolidated Net Profit

YoY Growth in quarter ended Jan 2013 is -100.00% vs 11.25% in Jan 2012

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'22

Change(%)

Net Sales

36.20

54.20

-33.21%

Operating Profit (PBDIT) excl Other Income

0.70

-4.70

114.89%

Interest

0.50

0.40

25.00%

Exceptional Items

0.00

-0.20

100.00%

Consolidate Net Profit

-6.10

-5.90

-3.39%

Operating Profit Margin (Excl OI)

12.70%

-106.80%

11.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -33.21% vs -51.56% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.39% vs -356.52% in Dec 2022

All Annual Results

Company CV

About Euromedis Groupe SA

Euromedis Groupe SA

Retailing

Euromedis Groupe SA is a France-based company that specializes in the design, manufacture, distribution, rental and export of medical and surgical equipment and products, and services for medical home care for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The Company's product portfolio include products, such as syringes and needles; surgical equipment, such as catheters, instrumentation and compresses; gloves; hygiene products, comprising disposable clothing, masks and paper towel products, and pharmaceutical equipment, offering cotton wool and thermometers. Euromedis Groupe SA exports its products to Europe and Africa.

Company Coordinates

Company Details

Zi De La Tuillerie , NEUILLY-SOUS-CLERMONT None : 60290

Tel: 33 3 44738360

https://www.euromedis.fr/

Registrar Details